Plain-English translation of NCT06988605 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study observes how well nemolizumab works for people with moderate-to-severe atopic dermatitis—a condition that causes intense itching and skin inflammation. Your doctor will have already decided whether this medication is right for you before you join the study. The research simply tracks how the medication performs during your regular doctor visits over about 12 months, without adding extra appointments or tests.
While this medication has been tested in clinical trials, researchers want to understand how well it works for real patients in everyday medical settings—not just in controlled research environments. This real-world data helps doctors and patients know what to expect when using this treatment.
You likely qualify if…
You likely don't qualify if…
You will take the medication as prescribed by your doctor and attend your regular skin care appointments—no extra visits are required. Your doctor will assess how your skin is responding, and you may be asked to fill out simple questionnaires about your symptoms like itching and sleep quality. In some locations, you may also track your itching and sleep on a daily basis for the first two weeks using your phone or computer. The study lasts about 12 months.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States